Clinical Trial

Bodewell Products for the Treatment of Atopic Dermatitis

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to examine the safety and efficacy of topical application of the Bodewell eczema products
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-09-29; most recent amendment 2026-02-26.
Status change: Recruiting → Active, Not Recruiting 2026-02-26
Status change: Not Yet Recruiting → Recruiting 2024-02-28
Trial Details
NCT Number NCT05566262
Lead Sponsor University of Alabama at Birmingham
Collaborators: Procter and Gamble
Conditions Atopic Dermatitis
Enrollment 15 participants
Start Date 2023-11-01
Primary Completion 2027-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-02